Cytogenetic studies on commercial hexane solvent

✍ Scribed by W. C. Daughtrey; D. L. Putman; J. Duffy; A. I. Soiefer; C. J. Kirwin; L. N. Curcio; T. H. Keenan

• Book ID: 102291228
• Publisher: John Wiley and Sons
• Year: 1994
• Tongue: English
• Weight: 449 KB
• Volume: 14
• Category: Article
• ISSN: 0260-437X
• DOI: 10.1002/jat.2550140303

✦ Synopsis

Abstract

Commercial hexane is a solvent mixture of six‐carbon isomers, consisting principally of n‐hexane, 3‐methylpentane, methylcyclopentane and 2‐methylpentane. The potential of commercial hexane to produce chromosome aberrations was evaluated in both an in vitro assay using Chinese hamster ovary (CHO) cells and an in vivo cytogenetics assay using Sprague‐Dawley rats. The CHO cells were exposed to media containing commercial hexane at concentrations of 0.014–0.42 μl ml^−1^ in the presence and absence of an S‐9 activation mixture. Cellular toxicity was observed at the higher dose levels, but no increase in chromosome aberrations was observed in either the non‐activated or S‐9‐activated systems. For the in vivo cytogenetics assay, rats were exposed nose‐only for 6 h per day for 5 consecutive days to commercial hexane vapor at target concentrations of 900, 3000 and 9000 ppm. Bone marrow cells were collected at 6 and 24 h after the midpoint of the last exposure. Metaphase cells were examined microscopically for chromosome aberrations. No statistically significant increases in aberrant cells were observed in the commercial hexane‐exposed animals of any dose group at either of the bone marrow harvest times. In conclusion, commercial hexane did not produce chromosomal mutations under the conditions of these studies.